BACKGROUND: Eczema vaccinatum (EV), a disseminated viral skin infection, is a life-threatening complication of vaccinia virus (VV) inoculation in patients with atopic dermatitis (AD) and is thought to be associated with a defective innate immune response. However, the precise mechanism or mechanisms and key factor or factors of EV are unknown. OBJECTIVE: Given that patients with psoriasis, another inflammatory skin disorder, are not susceptible to EV, we compared the global transcriptional response of skin to VV in healthy subjects, patients with psoriasis, and patients with AD, focusing on AD-specific genes. We hypothesized that differences in the transcriptional response to VV between patients with AD and patients with psoriasis or healthy subjects would identify a defective pathway or pathways that might be associated with the development of EV. METHODS: Gene expression profiling of sham-treated and VV-treated unaffected skin explants from patients with AD (n = 12), patients with psoriasis (n = 12), or healthy subjects (n = 13) were generated with U133_Plus2 (54,613 probe sets) GeneChips and analyzed with the GCOS_1.4/SAM_2.1/MAPPFinder_2.0 pipeline. RESULTS: Sixty-seven genes were significantly affected by VV in AD skin but not in psoriatic and healthy skin. Genes associated with defense response, response to wounding, and immune response were the most affected by VV in AD skin. All genes in these ontologies were downregulated, including the innate immunity genes leukotriene B(4) receptor (LTB4R), orosomucoid 1 (ORM1), coagulation factor II (thrombin) receptor (F2R), complement component 9 (C9), and LPS-binding protein (LBP). These findings were confirmed by means of real-time PCR and validated by means of PubMatrix analysis. ORM1, Toll-like receptor 4 (TLR4), and NLR family pyrin domain containing 1 (NLRP1) genes were also linked to AD severity. CONCLUSION: This study identified groups of innate immunity genes that are associated with the aberrant response of AD skin to VV and represent potential targets for EV pathogenesis. Copyright 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.
BACKGROUND: Eczema vaccinatum (EV), a disseminated viral skin infection, is a life-threatening complication of vaccinia virus (VV) inoculation in patients with atopic dermatitis (AD) and is thought to be associated with a defective innate immune response. However, the precise mechanism or mechanisms and key factor or factors of EV are unknown. OBJECTIVE: Given that patients with psoriasis, another inflammatory skin disorder, are not susceptible to EV, we compared the global transcriptional response of skin to VV in healthy subjects, patients with psoriasis, and patients with AD, focusing on AD-specific genes. We hypothesized that differences in the transcriptional response to VV between patients with AD and patients with psoriasis or healthy subjects would identify a defective pathway or pathways that might be associated with the development of EV. METHODS: Gene expression profiling of sham-treated and VV-treated unaffected skin explants from patients with AD (n = 12), patients with psoriasis (n = 12), or healthy subjects (n = 13) were generated with U133_Plus2 (54,613 probe sets) GeneChips and analyzed with the GCOS_1.4/SAM_2.1/MAPPFinder_2.0 pipeline. RESULTS: Sixty-seven genes were significantly affected by VV in AD skin but not in psoriatic and healthy skin. Genes associated with defense response, response to wounding, and immune response were the most affected by VV in AD skin. All genes in these ontologies were downregulated, including the innate immunity genes leukotriene B(4) receptor (LTB4R), orosomucoid 1 (ORM1), coagulation factor II (thrombin) receptor (F2R), complement component 9 (C9), and LPS-binding protein (LBP). These findings were confirmed by means of real-time PCR and validated by means of PubMatrix analysis. ORM1, Toll-like receptor 4 (TLR4), and NLR family pyrin domain containing 1 (NLRP1) genes were also linked to AD severity. CONCLUSION: This study identified groups of innate immunity genes that are associated with the aberrant response of AD skin to VV and represent potential targets for EV pathogenesis. Copyright 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.
Authors: Dmitry N Grigoryev; Shwu-Fan Ma; Larissa A Shimoda; Roger A Johns; Byungkook Lee; Joe G N Garcia Journal: Mol Cell Probes Date: 2006-09-19 Impact factor: 2.365
Authors: Ichiro Nomura; Bifeng Gao; Mark Boguniewicz; Marc A Darst; Jeffrey B Travers; Donald Y m Leung Journal: J Allergy Clin Immunol Date: 2003-12 Impact factor: 10.793
Authors: Surabhi Vora; Inger Damon; Vincent Fulginiti; Stephen G Weber; Madelyn Kahana; Sarah L Stein; Susan I Gerber; Sylvia Garcia-Houchins; Edith Lederman; Dennis Hruby; Limone Collins; Dorothy Scott; Kenneth Thompson; John V Barson; Russell Regnery; Christine Hughes; Robert S Daum; Yu Li; Hui Zhao; Scott Smith; Zach Braden; Kevin Karem; Victoria Olson; Whitni Davidson; Giliane Trindade; Tove Bolken; Robert Jordan; Debbie Tien; John Marcinak Journal: Clin Infect Dis Date: 2008-05-15 Impact factor: 20.999
Authors: Annika M Sääf; Maria Tengvall-Linder; Howard Y Chang; Adam S Adler; Carl-Fredrik Wahlgren; Annika Scheynius; Magnus Nordenskjöld; Maria Bradley Journal: PLoS One Date: 2008-12-24 Impact factor: 3.240
Authors: Kevin G Becker; Douglas A Hosack; Glynn Dennis; Richard A Lempicki; Tiffani J Bright; Chris Cheadle; Jim Engel Journal: BMC Bioinformatics Date: 2003-12-10 Impact factor: 3.169
Authors: Richard B Kennedy; Inna G Ovsyannikova; V Shane Pankratz; Iana H Haralambieva; Robert A Vierkant; Gregory A Poland Journal: Hum Genet Date: 2012-05-19 Impact factor: 4.132
Authors: P Gao; D N Grigoryev; N M Rafaels; D Mu; J M Wright; C Cheadle; A Togias; T H Beaty; R A Mathias; J T Schroeder; K C Barnes Journal: Clin Exp Allergy Date: 2010-07-04 Impact factor: 5.018
Authors: Donald Y M Leung; Pei-Song Gao; Dmitry N Grigoryev; Nicholas M Rafaels; Joanne E Streib; Michael D Howell; Patricia A Taylor; Mark Boguniewicz; Jennifer Canniff; Brian Armstrong; Daniel J Zaccaro; Lynda C Schneider; Tissa R Hata; Jon M Hanifin; Lisa A Beck; Adriana Weinberg; Kathleen C Barnes Journal: J Allergy Clin Immunol Date: 2011-04 Impact factor: 10.793
Authors: I-Hsin Kuo; Amanda Carpenter-Mendini; Takeshi Yoshida; Laura Y McGirt; Andrei I Ivanov; Kathleen C Barnes; Richard L Gallo; Andrew W Borkowski; Kenshi Yamasaki; Donald Y Leung; Steve N Georas; Anna De Benedetto; Lisa A Beck Journal: J Invest Dermatol Date: 2012-12-06 Impact factor: 8.551